Perfusio

Greenville, United States Founded: 2014 • Age: 12 yrs
Blood-flow imaging devices for surgical procedures are developed.

About Perfusio

Perfusio is a company based in Greenville (United States) founded in 2014. Perfusio has raised $7.79 million across 9 funding rounds from investors including HHS. Perfusio offers products and services including Certes. Perfusio operates in a competitive market with competitors including Haemonetics, VISIE, Sisu Global Health, Haermonics and i-sep, among others.

  • Headquarter Greenville, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website perfusio.com
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $7.79M (USD)

    in 9 rounds

  • Latest Funding Round
    $2.2M (USD), Seed

    Nov 2024

  • Investors

Products & Services of Perfusio

Perfusio offers a comprehensive portfolio of products and services, including Certes.

Certes
Surgical Imaging Tool

Provides real-time visualization of blood flow and tissue integrity in surgery.

Funding Insights of Perfusio

Perfusio has successfully raised a total of $7.79M across 9 strategic funding rounds. The most recent funding activity was a Seed round of $2.2 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.79M
  • Total Rounds 9
  • Last Round Seed β€” $2.2M
  • First Round $2M

    (Sep 2016)

  • Investors Count 1

All 9 funding rounds of Perfusio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2024$2.2MSeed––
–
Jul 2022$1.6MSeed––
–
Sep 2021$259,590Grant––
Aug 2020$2MSeries A––
–
Nov 2019$1.48MGrant––
–
Sep 2019$224,841Grant––
Mar 2019$868,741Debt – Conventional––
–
Aug 2017$1.68MGrant––
Sep 2016$2MAngel Round––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Perfusio

Perfusio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for Perfusio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Perfusio

16 people are tracked at Perfusio (5 in leadership, 11 in board & advisors).

NameRoleGroup
Monte B Tucker
CEOLeadership
Phil Hodges
CEOLeadership
Peter Geiger
CFOLeadership
Cheng Chen
Chief Science & Technical Officer, Co-FounderLeadership
Joffre Alvarez
Director, OperationsLeadership
George McGinn
Board MemberBoard & advisors
Rich Balot
Board MemberBoard & advisors
David B. Leeser
AdvisorBoard & advisors
Ashesh N. Buch
AdvisorBoard & advisors
David LaVance
Board MemberBoard & advisors
Mark A. Farber
AdvisorBoard & advisors
Kenichi Matsumura
Board MemberBoard & advisors
Steve Taylor
Board MemberBoard & advisors
Mercedes Dullum
AdvisorBoard & advisors
John M. Prager
AdvisorBoard & advisors
Bruce Ferguson
DirectorBoard & advisors
Premium access

Complete people profiles for Perfusio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Perfusio

3 dated milestones of Perfusio across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Perfusio is founded.
  2. Funding First funding round of $2.0M.
  3. Funding Latest funding round, Seed, of $2.2M.

Competitors of Perfusio

Perfusio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, VISIE, Sisu Global Health, Haermonics and i-sep, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
haemonetics.com1971Braintree, United States–3,034
Hematology products and solutions are provided for medical applications.
visievision.com2017Austin, United States$12.71M–
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery
sisuglobal.health2014Baltimore, United States––
Intraoperative autotransfusion devices are developed and provided.
haermonics.com2015Amsterdam, Netherlands$4.41M–
Postoperative pericardial drainage and flushing system is developed.
i-sep.com2015Nantes, France$3.61M–
Cell salvage solutions for autologous blood transfusion during surgery
procellsi.com2015Canton, United States––
Develops medical devices for intraoperative blood recovery and conservation.
swabtech.co.uk2012Manchester, United Kingdom$938,127–
Offers a device for intra-operative blood recovery from swabs.
gatescience.com2020Boston, United States$150,000–
Developer of a multi-modal device for post-surgery pain
scinovia.com2014Durham, United States$6.91M10
Augmented-reality surgical cameras for blood flow visualization are developed.
bonvisi.com2013Nacka, Sweden––
Endoscopic pump systems for urological procedures are manufactured by Bonvisi.
Premium access

Detailed competitors of Perfusio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Perfusio

Premium access

Complete news archive for Perfusio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Perfusio

10 companies that operate in the same segment as Perfusio (Medical Equipment & Supplies), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Software and integrated solutions for surgical and radiotherapy applications
1989Munchen, Bayern, GermanyUSD 12.68 MUSD 1.18 M18
Robotic waterjet system for prostate tissue removal is developed.
2009Redwood City, California, United StatesUSD 348.84 MUSD 308.05 M756
Collaborative surgical robotic systems are provided for hospital procedures.
2014Cambridge, Cambridgeshire, United KingdomUSD 1.32 B––
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.17 M–242
Augmented reality systems for guiding surgical procedures are developed.
2014Yokneam Illit, North District, IsraelUSD 142.6 M––
Manufacturer of imaging and surgical products
1919Tokyo, Tokyo, Japan–USD 6.49 B35,933
Injectable packaging, containment, and delivery solutions are manufactured.
1923Exton, Pennsylvania, United States–USD 3.07 B10,600
Rapid infusion systems are provided for critically ill patients.
2012Durham, North Carolina, United StatesUSD 77.98 M––
Mobile robots are manufactured for industries including healthcare and agriculture.
2013Odense, DenmarkUSD 81.44 M–303
Visualization systems for surgical procedures are developed using machine learning.
2016Seattle, Washington, United StatesUSD 74.25 M–52
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Perfusio

Perfusio was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Perfusio is headquartered in Greenville, United States.

Monte B Tucker is the current CEO of Perfusio.

Perfusio is a funded company, having raised a total of $7.79M across 9 funding rounds to date. The company's 1st funding round was a Angel Round of $2M, raised on Sep 2016.

A blood-flow imaging device known as Certes was developed by Perfusio, founded in 2014 and based in Greenville, United States. Real-time visualization of blood flow and perfusion in vascular structures and tissues is provided during surgeries. Complications in procedures are reduced through hemoglobin flow monitoring. Operations focus on medical imaging technology within the healthcare sector, serving surgical applications across the region.

Perfusio's top competitors include Haemonetics, VISIE and Sisu Global Health.

Perfusio offers Certes.

Perfusio has 1 investor. Key investors include HHS.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available